Michigan Supreme Court paves way to strengthen state consumer protection act

An investigation into insulin prices in Michigan resulted in a court ruling with broader implications for consumer protections.

• Aug 3

Eli Lilly weight loss pill shows promise in latest clinical trial

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

• Aug 7, 2025

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

• Apr 18, 2025

FDA approves new Alzheimer's treatment from Eli Lilly

FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.

• Jul 3, 2024

Drugmakers hike prices on more than 700 drugs, including Ozempic

Some popular medications are among those getting pricier at the start of 2024, including weight-loss drugs Ozempic and Mounjaro.

• Jan 18, 2024

FDA approves a new weight loss drug, Zepbound from Eli Lilly

The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.

• Nov 8, 2023

Eli Lilly says its Alzheimer's drug appears to slow symptoms

Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab.

• May 3, 2023